Linda S. Grais is President at Ocera Therapeutics, Inc. (OCRX). They have made 7 open-market trades across 2 companies since 2010, most recently 2020-06-25.
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
6 open-market purchases totalling $240K since 2014, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OCRX | BUY | 2016-12-07 | 2016-12-08 | $2.14 | $15K | N/A | N/A | N/A |
| OCRX | BUY | 2016-03-04 | 2016-03-07 | $3.19 | $10K | N/A | N/A | N/A |
| OCRX | BUY | 2016-01-22 | 2016-01-25 | $2.38 | $24K | N/A | N/A | N/A |
| OCRX | BUY | 2016-01-15 | 2016-01-19 | $2.08 | $21K | N/A | N/A | N/A |
| OCRX | BUY | 2015-05-06 | 2015-05-06 | $3.73 | $112K | N/A | N/A | N/A |
| OCRX | BUY | 2014-07-11 | 2014-07-15 | $5.93 | $59K | N/A | N/A | N/A |
| ABIO | SELL | 2010-03-29 | 2010-03-30 | $7.38 | $1.6M | -24.1% | +0.9% | +0.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.